Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Naoki Ishibashi is active.

Publication


Featured researches published by Naoki Ishibashi.


Bioorganic & Medicinal Chemistry Letters | 2011

Identification of 4-quinolone derivatives as inhibitors of reactive oxygen species production from human umbilical vein endothelial cells

Kenichi Onda; Fumie Narazaki; Naoki Ishibashi; Keita Nakanishi; Yuki Sawada; Kenichiro Imamura; Kazuhiro Momose; Shigetada Furukawa; Yoshiaki Shimada; Hiroyuki Moriguchi; Masamichi Yuda; Hiroshi Kayakiri; Mitsuaki Ohta

Oxidative stress is widely recognized as being associated with a number of disorders, including metabolic dysfunction and atherosclerosis. A series of substituted 4-quinolone derivatives were prepared and evaluated as inhibitors of reactive oxygen species (ROS) production from human umbilical vein endothelial cells (HUVECs). One compound in particular, 2-({[4-(3-hydroxy-3-methylbutoxy)pyridin-2-yl]oxy}methyl)-3-methylquinolin-4(1H)-one (25b), inhibited ROS production from HUVECs with an IC(50) of 140 nM. This compound also exhibited low CYP2D6 inhibitory activity, high aqueous solubility, and good in vitro metabolic stability. An in vivo pharmacokinetic study of this compound in SD rats revealed high oral bioavailability and a long plasma half-life.


Archive | 2004

Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors

Naoki Ishibashi; Kazunori Kamijo; Shigeki Fujisawa Pharmaceutical Co. Ltd. Satoh; Yasuharu Urano


Archive | 1999

Imidazole compounds and medicinal use thereof

Hiroshi Kayakiri; Yoshito Abe; Hitoshi Hamashima; Hitoshi Sawada; Naoki Ishibashi; Hiroyuki Setoi; Noritsugu Yamasaki; Takafumi Imoto; Takahiro Hiramura; Teruo Oku


Archive | 2005

Hydroxyamide compounds having activity as inhibitors of histone deacetylase (hdac)

Naoki Ishibashi; Yuki Sawada; Yasuharu Urano; Shigeki Satoh; Yoshikazu Inoue; Yoshiteru Eikyu; Koichiro Mukoyoshi; Kazunori Kamijo; Fumiyuki Shirai; Hisashi Takasugi


Archive | 1999

Sulfonamide compounds and uses thereof as medicines

Hiroshi Kayakiri; Yoshito Abe; Hitoshi Hamashima; Hitoshi Sawada; Naoki Ishibashi; Hiroyuki Setoi; Noritsugu Yamasaki; Takafumi Imoto; Takahiro Hiramura; Teruo Oku


Archive | 2002

Substituted dipeptides having nos inhibiting activity

Ichiro Shima; Takehiko Ohkawa; Kazuhiko Ohne; Kentaro Sato; Naoki Ishibashi; Kenichiro Imamura


Archive | 2002

Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors

Masahiro Neya; Akihiko Sawada; Kazuhiko Ohne; Yoshito Abe; Tsuyoshi Mizutani; Naoki Ishibashi; Makoto Inoue


Archive | 2008

Dérivé de quinolone

Kenichi Onda; Kenichiro Imamura; Fumie Sato; Hiroyuki Moritomo; Yasuharu Urano; Yuki Sawada; Naoki Ishibashi; Keita Nakanishi; Kazuhiro Yokoyama; Shigetada Furukawa; Kazuhiro Momose


Archive | 2007

Derive de phenylthiazole

Takeshi Kato; Takayuki Suzuki; Kenichi Onda; Masakazu Imamura; Keita Nakanishi; Takanori Koike; Mitsuaki Okumura; Naoki Ishibashi; Masanori Yokono; Ichiro Takase; Takahiro Hiramura


Archive | 2005

Composés d'hydroxyamide présentant une activité en tant qu'inhibiteurs d'histone désacétylase (hdac)

Naoki Ishibashi; Yuki Sawada; Yasuharu Urano; Shigeki Satoh; Yoshikazu Inoue; Yoshiteru Eikyu; Koichiro Mukoyoshi; Kazunori Kamijo; Fumiyuki Shirai; Hisashi Takasugi

Collaboration


Dive into the Naoki Ishibashi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge